-
R1078 OX40L mRNA: A Causal Assay Framework
2026-09-21
Explore how EZ Cap™ Mouse CD252(OX40L) mRNA (m1Ψ, HA tag) can be used to separate ligand expression, OX40 signaling, and downstream T-cell function. This article translates related mRNA co-stimulation evidence into a rigorous causal assay strategy without overstating what the literature proves.
-
Lopinavir in MERS-CoV Drug Repurposing
2026-09-21
de Wilde et al. screened an FDA-approved library in a cell-based MERS-CoV assay and identified Lopinavir (ABT-378) alongside three other compounds with low-micromolar antiviral activity. The study demonstrates how phenotypic drug repurposing can rapidly generate candidates for emerging coronavirus research while also showing why cell culture activity requires mechanistic, pharmacological, and in vivo validation.
-
Vasopressin Analogues: Evidence and Translation
2026-09-20
Glavaš et al. review how vasopressin structure, receptor selectivity, and peptide engineering produced analogues with distinct antidiuretic, vasoconstrictive, and therapeutic profiles. The analysis positions lypressin and synthetic analogues as useful models for connecting receptor pharmacology with clinical translation while emphasizing peptide stability, delivery, and the preliminary nature of antiviral hypotheses.
-
SM-102 Workflow for mRNA Delivery
2026-09-19
Build a more reproducible mRNA delivery workflow around SM-102 by controlling solvent handling, rapid lipid–RNA mixing, physicochemical quality control, and cell-based validation. The article also contrasts SM-102 lipid nanoparticles with a polyphenol–polypeptide platform that offers pH-responsive nucleic acid release.
-
Sequencing Therapy in Waldenström Macroglobulinemia
2026-09-18
The 2021 reference paper reframes Waldenström macroglobulinemia treatment selection as a genotype- and patient-informed sequencing problem rather than a fixed regimen hierarchy. Its central practical contribution is linking MYD88 and CXCR4 status with expected treatment response, while emphasizing clinical presentation, comorbidities, toxicity, patient preference, and clinical-trial access.
-
Bazedoxifene Blocks Malaria Growth and Hemozoin Formation
2026-09-18
The reference study identifies bazedoxifene, a third-generation selective estrogen receptor modulator, as an inhibitor of blood-stage Plasmodium growth and hemozoin formation. Its stage-selective activity, effects in drug-resistant parasites, and sex-dependent response in mice support drug repurposing while also defining important limits for translation.
-
2-Thio-dCTP for Precision DNA Assays
2026-09-17
2-Thio-dCTP enables controlled sulfur substitution in DNA for polymerase selectivity, site-specific DNA modification, and DNA–protein interaction studies. This practical guide also explains how to keep nucleotide chemistry separate from the SCP4–H3T3 chromosome-stability pathway while using orthogonal assays to strengthen mechanistic conclusions.
-
Toremifene Citrate: An Assay-First Research Guide
2026-09-17
Toremifene Citrate is an oral selective estrogen receptor modulator with distinct value in estrogen receptor signaling and breast cancer research. This assay-first guide connects receptor pharmacology, comparative evidence, concentration selection, and translational interpretation without conflating laboratory potency with clinical efficacy.
-
Vasopressin and Its Analogues: Mechanisms and Translation
2026-09-16
The reference review explains how vasopressin structure, receptor selectivity, metabolic stability, and route of administration shape the behavior of natural and synthetic analogues. Its main practical contribution is a framework for connecting peptide chemistry with antidiuretic therapy, vasoconstriction research, receptor assays, and cautiously interpreted antiviral hypotheses.
-
Beyond Membrane Disruption: Translational Lessons from YZ462
2026-09-16
YZ462 illustrates how membrane disruption, permeability changes, endogenous ROS, and biofilm activity can inform a more disciplined antimicrobial development strategy. This article translates those findings into experimental decision points while positioning Recombinant Human IL-12 as a carefully controlled exploratory variable for host-context studies.
-
PD0325901 as a MEK Probe in Cell-State Assays
2026-09-15
PD0325901 is a selective MEK inhibitor for dissecting RAS/RAF/MEK/ERK signaling alongside differentiation and protein-secretion assays. This article shows how to pair pathway readouts with O-GlcNAc and galectin-3 measurements for more informative cell-state interpretation.
-
PDHA1 Succinylation Rewires Cholangiocarcinoma Immunity
2026-09-15
The reference study identifies PDHA1 lysine 83 succinylation as a metabolic-to-immune switch in cholangiocarcinoma. By increasing PDH activity and promoting α-ketoglutarate accumulation, this modification activates macrophage OXGR1–MAPK signaling, suppresses MHC-II antigen presentation, and may contribute to chemotherapy resistance.
-
BteA, Akt/mTOR, and Bordetella Persistence
2026-09-14
The reference study identifies a previously underappreciated Bordetella strategy in which the T3SS effector BteA activates host Akt/mTOR signaling in epithelial cells and eosinophils to increase IL-1Ra expression. Genetic or antibody-mediated loss of IL-1Ra accelerated bacterial clearance in vivo, connecting eosinophil–epithelial communication with immune evasion and persistent respiratory infection.
-
Tamoxifen: Mechanisms, Evidence, and Research Use
2026-09-14
Tamoxifen is a selective estrogen receptor modulator with antagonist activity in breast tissue and agonist activity in selected other tissues. Its research value spans breast cancer research, CreER-mediated gene knockout, and cell-signaling studies, but dose-, tissue-, and exposure-specific effects require careful controls.
-
Cholecystokinin octapeptide ammonium: LTP Workflow
2026-09-13
Cholecystokinin octapeptide ammonium enables receptor-resolved studies of hippocampal plasticity, opioid-related memory impairment, neuronal survival, and broader brain–gut signaling. This workflow translates the CCK-2 receptor finding from a rat LTP model into practical assay design, handling controls, and troubleshooting decisions.